ArticleVirchows Archiv : an international journal of pathology2026
Cytochrome P450 as possible link between Mallory-Denk body formation in DDC-intoxicated mouse liver and human steatohepatitis.
Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Mallory-Denk bodies (MDBs) are hepatocytic inclusions in alcohol-related (ASH) and metabolic dysfunction-associated (MASH) steatohepatitis as well as in some other apparently etiologically different chronic human liver disorders. They are experimentally induced in mouse liver by chronic intoxication with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). Like in human diseases, mouse liver MDBs consist of stress proteins as major components indicating their relationship to chronic cellular stress. Mouse livers at different stages of DDC intoxication, recovery, and re-intoxication were analyzed with regard to cytochrome P450 (CYP) expression, enzyme activity, oxidative stress, and anti-oxidative response. mRNAs of cytochrome P450 2A5 (CYP2A5), heme oxygenase-1 (Hmox-1), and the ubiquitin-binding adapter protein p62/sequestosome1 (p62) were significantly elevated by DDC treatment. CYP2A5 protein correlated at the cellular level with the presence of MDBs, and CYP2A5-related coumarin 7-hydroxylase (COH) activity was increased in relation to MDB expression. A functional relationship between CYP2A5 and Hmox-1 activity was established by the identification of bilirubin as a potent inhibitor of the production of reactive oxygen species (ROS) by CYP2A5. Moreover, CYP2E1 as well as CYP2A6, which are induced in human steatohepatitis, showed similar H
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.